What is the mechanism of action of a proton pump inhibitor?
Abstract
Pariet - PPI proton pump inhibitors with the active ingredient rabeprazole, after passing through the stomach, enter the small intestine, where they dissolve, after which they first enter the liver through the bloodstream, and then penetrate the membrane of the parietal cells of the gastric mucosa. goes and there they accumulate in the secretion. tubules. Here, at acidic pH, proton pump inhibitors are activated and become tetracyclic mechanism of action of proton pump inhibitors (Maev I.V. et al.)
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.